Interrelations of serum leptin levels with adrenocorticotropic hormone, basal cortisol and dehydroepiandrosterone sulphate levels in patients with metabolic syndrome

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 4, Issue 1, 2010, Pages 13-17

  Özçelik, Eda ^a   Uslu, Sema ^a   Kebapçi, Nur ^a   Kara, Mehmet ^a   Dokumacioǧlu, Ali ^a   Musmul, Ahmet ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Leptin; Metabolic syndrome; Obesity

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; LEPTIN; PRASTERONE SULFATE;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

EID: 84860194733     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2010.01.005     Document Type: Article

References (49)

1. Amy ZF. Etiology of the metabolic syndrome. Curr Cardiol Rev 2007;3:232-9.
2. Schling P, Löffler G. Cross talk between adipose tissue cells: impact on pathophysiology. News Physiol Sci 2002;17:99-1043.
3. Arikan E. Obesity and metabolic syndrome. Turk Clin J Int Med Sci 2005;1:18-23.
4. Murakami T, Yamashita T, Iida M, Kuwajima M, Shima K. A short form of leptin receptorperformssignaltransduction. Biochem Biophys Res Commun 1997;231: 26-9.
5. Prins JB, O'Rahilly S. Regulation of adipose cell number in man. Clin Sci (Lond) 1997;92:3-11. (Pubitemid 27033005)
6. Schulze PC, Kratzsch J. Leptin as a new diagnostic tool in chronic heart failure. Clin Chim Acta 2005;362:1-11. (Pubitemid 41597085)
7. Lichnovská R, Gwozdziewiczová S, Chlup R, Hrebícek J. Serum leptin in the development of insulin resistance and other disorders in the metabolic syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005;149:119-26.
8. Liu Y, Nakagawa Y, Wang Y, Sakurai R, Tripathi PV, Lutfy K, et al. Increased glucocorticoid receptor and 11 (beta)-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes 2005;54:32-40. (Pubitemid 40105092)
9. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Salonen R, et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003;149:601-8. (Pubitemid 38054707)
10. Cleeman JI. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
11. Reimondo G, Pia A, Bovio S, Allasino B, Daffara F, Paccotti P, et al. Laboratory differentiation of Cushing's syndrome. Clin Chim Acta 2008;388:5-14. (Pubitemid 350266593)
12. World Health Organisation (WHO). Expert committee physical status the use and interpretation of anthropometry World Health Organisation Technical Report Series, vol. 854. Geneva: WHO; 1995. p. 1-452.
13. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropo-metric index of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-8. (Pubitemid 24096208)
14. Hannon TS, Bacha F, Lee SJ, Janosky J, Arslanian SA. Use of markers of dyslipidemia to identify overweight youth with insulin resistance. Pediatr Diabetes 2006;7:260-6. (Pubitemid 44593926)
15. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-95. (Pubitemid 38680001)
16. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev 2008;29:777-822.
17. Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: definition, pathophysiology and mechanisms. Am Heart J 2005;149:33-45. (Pubitemid 40126488)
18. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key featureofacardiovascular and metabolic syndrome. Diabetologia 1991;34:416-22.
19. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
20. Wilson WG, Kannel WB, Detz WH. Prevalence of the metabolic syndrome among US adults: findings from third National Health and Nutrition Examination Survey. JAMA 2002;281:356-9.
21. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008;28:1039-49.
22. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, et al. Identification and expression cloning of a leptin receptor OB-R. Cell 1995; 83:1263-71. (Pubitemid 26007816)
23. Wauters M, Considine RV, Van Gaal LF. Human leptin: from adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000;143:293-311.
24. Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401. (Pubitemid 28168737)
25. Cioffi JA, Shafer AW, Zupancic TJ, Smith-Gbur J, Mikhail A, Platika D, et al. Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nat Med 1996;2:585-9. (Pubitemid 26151519)
26. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5. (Pubitemid 26033933)
27. Goumenou AG, Matalliotakis IM, Koumantakis GE, Panidis DK. The role of leptin in fertility. Eur J Obstet Gynecol Reprod Biol 2003;106:118-24. (Pubitemid 36120454)
28. Zamboni M, Zoico E, Fantin F, Panourgia MP, Di Francesco V, Tosoni P, et al. Relation between leptin and the metabolic syndrome in elderly women. J Gerontol A Biol Sci Med Sci 2004;59:396-400. (Pubitemid 38478740)
29. Agata J, Masuda A, Takada M, Higashiura K, Murakami H, Miyazaki Y, et al. High plasma immunoreactive leptin level inessential hypertension. Am J Hypertens 1997;10:1171-4. (Pubitemid 27486351)
30. Suter PM, Locher R, Häsler E, Vetter W. Is there a role for the ob gene product leptin in essential hypertension. Am J Hypertens 1998;11:1305-11. (Pubitemid 28541045)
31. Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activation by leptin. Hypertension 1999;33:542-7.
32. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998;31:409-14.
33. Meisinger C, Loewel H, Mraz W, Koenig W. Prognostic value of apolipoprotein B and AI in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. Eur Heart J 2005;26:271-8. (Pubitemid 40222365)
34. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-g action in humans. Diabetes 2001;50:2199-220.
35. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002;13:18-23. (Pubitemid 36734011)
36. Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, et al. Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11-hydroxysteroid dehydrogenase type 1) gene. Mol Cell Endocrinol 2008;285:10-8.
37. Morton NM, Holmes MC, Fiévet C, Staels B, Tailleux A, Mullins JJ, et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 2001;276:41293-300.
38. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum". Lancet 1997;349:1210-3. (Pubitemid 27190044)
39. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-70. (Pubitemid 33150673)
40. Aldhahi W, Mun E, Goldfine AB. Portal and peripheral cortisol levels in obese humans. Diabetologia 2004;47:833-6. (Pubitemid 38756995)
41. Kershaw EE, Morton NM, Dhillon H, Ramage L, Seckl JR, Flier JS. Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 2005;54:1023-31. (Pubitemid 40446315)
42. Morton NM, Densmore V, Wamil M, Ramage L, Nichol K, Bünger L, et al. A polygenic model of the metabolic syndrome with reduced circulating and intra-adipose glucocorticoid action. Diabetes 2005;54:3371-8. (Pubitemid 43334325)
43. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CR. Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab 1995;80:3155-8.
44. Pasquali R, Vicennati V, Cacciari M, Pagotto U. The hypothalamic- pituitary- adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci 2006;1083:111-28. (Pubitemid 44955469)
45. Pasquali R, Vicennati V. The abdominal obesity phenotype and insulin resistance are associated with abnormalities of the hypothalamic-pituitary-adre- nal axis in human. Horm Metab Res 2000;32:521-5. (Pubitemid 32176081)
46. Hernandez-Morante JJ, Milagro F, Gabaldon JA, Martinez JA, Zamora S, Garaulet M. Effect of DHEA-sulfate on adiponectin gene expression in adipose tissue from different fat depots in morbidly obese humans. Eur J Endocrinol 2006;155:593-600. (Pubitemid 44608433)
47. Villareal DT, Holloszy JO, Kohrt WM. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin Endocrinol (Oxf) 2000;53:561-8.
48. Haffner SM, Valdez RA, Mykkänen L, Stern MP, Katz MS. Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism 1994;43:599-603. (Pubitemid 24145467)
49. Barrett-Connor E, Ferrara A. Dehydroepiandrosterone, dehydroepiandroster- one sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J Clin Endocrinol Metab 1996;81:59-64.